MCF-7 CDX Model 

The MCF-7 cell line originates from human breast cancer and is one of the most extensively studied and utilized cell lines in breast cancer research. MCF-7 cells represent the Luminal A subtype, which is estrogen receptor-positive (ER+) and progesterone receptor-positive (PR+), but HER2-negative. The cell line serves as a fundamental tool for understanding the biology and hormonal regulation of breast cancer and for evaluating hormone-based and targeted therapeutic interventions. MCF-7 showcases many of the molecular features and genetic alterations typical of the Luminal A subtype, making it an invaluable model for preclinical investigations. Its behavior both in vitro and in vivo offers insights into the growth dynamics of hormone-sensitive breast cancers, their responses to endocrine therapies, and mechanisms of resistance. Researchers widely use MCF-7 to study the intricacies of breast cancer biology, hormonal pathways, and to assess the efficacy of therapeutic compounds, particularly those targeting the estrogen receptor.

Model Details

Cancer Location: Mammary Fat Pad
Cancer Type: Breast Cancer
Model Name: MCF-7
Mouse Strain: NSG

MCF-7 Growth

Growth of orthotopic (MFP) MCF-7  in NSG mice (n=5)

Request Additional Syngeneic Model Data

Contact Us

Get Started.

Have questions about how TD2 can assist with your regulatory needs? Reach out to our
expert staff today to get started.

Skip to content